Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results
Go back to Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results| (NASDAQ: ESTA) | Delayed: 86.06 +1.25 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.81 | 52 Week High | $ | |||
| Open | $85.67 | 52 Week Low | $ | |||
| Day High | $89.18 | P/E | N/A | |||
| Day Low | $85.21 | EPS | $ | |||
| Volume | 620,404 | |||||
